Do APOE4 and long COVID-19 increase the risk for neurodegenerative diseases in adverse environments and poverty?
Gabriella C. V. Ciurleo,
José Wagner Leonel Tavares-Júnior,
Carlos Meton A. G. Vieira,
Pedro Braga-Neto,
Pedro Braga-Neto,
Reinaldo B. Oriá
Affiliations
Gabriella C. V. Ciurleo
Laboratory of the Biology of Tissue Healing, Ontogeny and Nutrition, Department of Morphology and Institute of Biomedicine, School of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil
José Wagner Leonel Tavares-Júnior
Neurology Division, Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil
Carlos Meton A. G. Vieira
Laboratory of the Biology of Tissue Healing, Ontogeny and Nutrition, Department of Morphology and Institute of Biomedicine, School of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil
Pedro Braga-Neto
Neurology Division, Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil
Pedro Braga-Neto
Health Sciences Center, State University of Ceará, Fortaleza, Ceará, Brazil
Reinaldo B. Oriá
Laboratory of the Biology of Tissue Healing, Ontogeny and Nutrition, Department of Morphology and Institute of Biomedicine, School of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil
